Stocks · Health care · Pharmaceutical Preparations

Spyre Therapeutics, Inc.

SYRE Clue Score15

United States Fiscal year ends December CIK 0001636282 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$441.93M

$19.91M on a plan · $422.03M straight out of an exercise

Sold at will

$0.00

0 of 94 sales

Net

−$441.93M

$0.00 against sales at will